NIDA Avant-Garde-Medications Development Award winners announced

Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA’s second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr. Peter Burkhard, of the University of Connecticut, Storrs, will each receive $500,000 per year for five years to … Read more

XMRV and related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients

A study supported by the U.S. Department of Health and Human Services could not validate or confirm previous research findings that suggested the presence of one of several viruses in blood samples of people living with chronic fatigue syndrome. The new study also could not find the viruses in blood samples of healthy donors who … Read more

NHGRI funds development of revolutionary DNA sequencing technologies

Researchers today received more than $14 million in grants to develop DNA sequencing technologies that will rapidly sequence a person’s genome for $1000 or less. The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, awarded the grants to enable the everyday use of DNA sequencing technologies by biomedical researchers and … Read more

Second Annual National Drug Facts Week Begins Oct. 31st

Teens and drug experts will connect for the second annual National Drug Facts Week, held Oct. 31 through Nov. 6. This week-long observance will bring together teens and scientific experts in community events across the country to discuss scientific facts about drug abuse. It is sponsored by the National Institute on Drug Abuse (NIDA), a … Read more

Medicare Supplement Notice of Creditable: NonCreditable Coverage

Members began receiving their annual notice of Creditable or NonCreditable prescription drug coverage in early September; those notices will be delivered to Members began receiving their annual notice of Creditable or NonCreditable prescription drug coverage in early September; those notices will be delivered to members through the end of the month. This disclosure is required by … Read more

Tightens Financial Conflict of Interest Rules for Researchers

The U.S. Department of Health and Human Services today issued an updated Final Rule on conflict of interest, providing a framework for identifying, managing, and ultimately avoiding investigators’ financial conflicts of interest Staff from the National Institutes of Health worked with others in HHS to revise the 1995 regulations to update and enhance the objectivity … Read more